Alembic Pharmaceuticals Limited (APLLTD) — Long-term Investment Intensity
Alembic Pharmaceuticals Limited (APLLTD) has a Long-term Investment Intensity of 0.3% as of September 2019. Long-term investments of Rs171.00 Million represent 0.3% of total assets of Rs56.08 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Alembic Pharmaceuticals Limited cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Alembic Pharmaceuticals Limited Long-term Investment Intensity (2014–2019)
This chart shows how Alembic Pharmaceuticals Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 0.3%, reflecting long-term investments of Rs171.00 Million against total assets of Rs56.08 Billion INR. Explore APLLTD debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Alembic Pharmaceuticals Limited (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Alembic Pharmaceuticals Limited from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see APLLTD market cap.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.0% | Rs487.60 Million | Rs47.78 Billion | ▼ 0.0 pp |
| 2018 | 1.1% | Rs416.40 Million | Rs39.41 Billion | ▼ -0.8 pp |
| 2017 | 1.9% | Rs498.80 Million | Rs26.87 Billion | ▼ -1.7 pp |
| 2016 | 3.5% | Rs867.30 Million | Rs24.59 Billion | ▲ +3.4 pp |
| 2015 | 0.1% | Rs22.64 Million | Rs16.41 Billion | ▼ -0.1 pp |
| 2014 | 0.3% | Rs33.56 Million | Rs12.18 Billion | — |